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Weaned rabbits were fed diets contaminated with 2 mg/kg diet T-2 toxin alone, or 10 mg/kg diet fumonisin B1 (FB1)
alone, and both toxins in combination (2+ 10 mg/kg, respectively) compared to a toxin-free control diet. Samplings
were performed after 4 weeks (blood and liver). Bodyweight of T-2-fed group was lower after 4 weeks; the liver
weight was increased dramatically (threefold of control). Liver total phospholipids (PLs) provided slight alterations
in the fatty acid (FA) composition; all three toxin-treated groups showed a decrease in palmitoleic acid (C16:1 n7)
proportion. In the liver mitochondrial PL FA composition, margaric acid (C17:0) proportion decreased in the
separated toxin treatments compared to the combined setting. Oleic acid (C18:1 n9) proportion was increased and
arachidonic acid (C20:4 n6) was decreased in the FB1-treated group, while docosapentaenoic acid (C22:5 n3) was
decreased in the separated treatments. The total monounsaturation was signiﬁcantly higher in the FB1 group’s
mitochondrial PL FA proﬁle. After 4 weeks, all toxin treatments decreased the blood plasma reduced glutathione and
glutathione peroxidase activity, and FB1 increased the plasma sphinganine/sphingosine ratio. Both mycotoxins seem
to cross the hepatocellular and the hepatic mitochondrial membrane, without drastic membrane disruption, as
assessed from the PL FA composition, but inducing detectable lipid peroxidation.
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Introduction
Mycotoxins are secondary metabolites of fungal (mold) metabolism with various biological
activities, e.g., protein (T-2) or ceramide (fumonisin B1, FB1) synthesis inhibition, but T-2
and FB1 in high concentrations and prolonged consumption are carcinogens as well (9, 11,
13). Since most fungal strains produce single or multiple mycotoxins, their combined effects
are nowadays in focus (12).
T-2 toxin is a trichothecene, produced by Fusarium species, occurring mostly in corn
and further cereals. T-2 toxin is metabolized (hydrolyzed to HT-2) after ingestion, yielding
multiple metabolites with known or less known toxicity and membrane association
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capability (9). Their mode of toxic action is rather divergent, as the inhibition of protein
synthesis (speciﬁcally in eukaryotes) and inhibition of DNA synthesis (9), or the disruption of
the mitochondrial electron transport system (26), augmented lipid peroxidation, affecting
ultimately cell membrane integrity. According to Ngampongsa et al.’s study (26), the ATP-
linked oxygen consumption rate of cardiomyocyte mitochondria is compromised by T-2
toxin, which is underpinned with our recent results, in which rabbit erythrocyte Na+/K+
ATPase activity (the rate of ATP breakdown) was markedly lowered by T-2 toxin (33). It was
established that in the rat liver, T-2 toxin inhibits the mitochondrial electron transport system,
concluding that mitochondria are possible hepatic targets of T-2 toxin action (27). It is
important to add that even in embryonic stem cells (being pluripotent), T-2 toxin induced
apoptosis via a reactive oxygen species-mediated mitochondrial pathway (14). In summary, it
is proven that T-2 toxin crosses the hepatic cellular and subcellular membranes and disrupts
ATP production in mitochondria (28). An essential addition is that hepatic subcellular
distribution of labeled [3H]T-2 toxin revealed immediate association to the plasma membrane
and a concomitant association to the membranes of other cellular compartments, including
mitochondria (28). Anyhow, T-2 toxin is less known considering its membrane disruptor
effect exerted during its transmembrane movement on which this study was focused. The
question is even more intriguing taking the solubility of pure T-2 toxin into account, namely,
it is only weakly water soluble (3).
Molecular-compositional changes underlying the hepatic membrane lipid alterations
(alteration of the lipid proﬁle of phospholipid (PL) classes in the microsomal, the nuclear, and
the cellular membranes) caused by FB1 were partly elucidated when feeding rats with a
drastically toxic, cancer promoting toxin level (250 mg/kg feed) (6). In the same study, FB1
altered lipid constituent proportions; in particular, phosphatidylethanolamines (PEs) were
signiﬁcantly increased in the mitochondrial and even in the plasma membrane fractions. The
fatty acid (FA) proﬁle of the main polar lipid fractions (i.e., P-choline and PE) showed a
decrease in polyunsaturated (especially C20:4 n6, arachidonic acid)/saturated (P/S) FA ratio,
suggesting a less ﬂuid membrane state. The decreased polyunsaturated FA levels in
phosphatidylcholine (PC) along with a marked elevation of oleic (C18:1 n9) and linoleic
(C18:2 n6) acids were indicative of an impaired delta-6 desaturase activity. The authors
concluded that FB1 disrupts sphingolipid, PL (the polar lipid fractions interaction with a polar
toxin molecule), cholesterol, and FA metabolism in the liver, in a manner to decrease
membrane ﬂuidity (ultimately leading to apoptosis). Arachidonic acid has a profound role in
this, namely, the outer plasma membrane lipid leaﬂet is enriched with this acid, being the
precursor of inﬂammatory eicosanoids.
Since both T-2 and FB1 are unequivocal membrane disruptors even at the subcellular
level, their detailed study is reasoned.
The co-occurrence of mycotoxins makes the cytotoxicity assessment more complex,
meanwhile Clarke et al. (10) used the EU regulation concentration limits for FB1, ochratoxin,
and aﬂatoxin B1 in a tertiary combination (10). In our recent study, it was found that at levels
of 2 mg/kg diet T-2 toxin alone, or 10 mg/kg diet fumonisin B1 (FB1) alone, and both toxins
in combination exerted hepatotoxic effect and acted antagonistically onto the red cell sodium
pump ATP breakdown capacity, T-2 markedly lowering its activity (33). However, red cell
membrane fatty acyl chain composition was only slightly modiﬁed in the cells of the systemic
circulation, supposing that both toxins act at the level of polychromatic erythroblasts. Here,
we tested the effects of the same toxin exposure onto the hepatic membrane and hepatic
mitochondrial membrane composition and investigated possibly emerging lipid peroxidation.
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Materials and Methods
Experimental design
Pannon white littermate male rabbits weaned at the age of 35 days were caged as pairs, and
four groups were formed, each containing 10 animals. The animals were born, housed, and
treated at the rabbitry of the experimental farm of the Kaposvár University. One group was
fed a rabbit diet complemented with 2 mg/kg T-2 toxin, another group was fed the same basal
diet complemented with 10 mg/kg FB1, while a further group was given T-2 and FB1 in a
combined form (2+ 10 mg/kg diet). The control group was fed a toxin-free diet containing
the same ingredients as the experimental ones, with the exception of fungal cultures. Feed and
water were ad libitum offered. Bodyweight and feed intake were measured weekly,
individually, and the entire feeding period lasted for 4 weeks. All data were recorded on
individually marked animals, from six rabbits (chosen out randomly of the total of 10) in each
group.
Production of toxins and determination of mycotoxin content in fungal cultures and feeds
FB1 and T-2 toxin were produced with the application of Fusarium verticillioides strain MRC
826 and Fusarium sporotrichioides strain NRRL 3299, respectively (15). The homogenized
fungal cultures contained FB1 at a concentration of 3,440 mg/kg, while T-2 toxin concen-
tration was 1,338 mg/kg (HT-2 toxin 285 mg/kg), respectively. These fungal cultures were
mixed into the basal feed of the experimental animals, so as to provide contaminated feeds
with 2 mg/kg feed T-2 toxin and/or 10 mg/kg feed FB1.
The mycotoxin concentration of the control and the experimental feeds was determined
with LC-MS (Shimadzu, Kyoto, Japan). The limit of detection for FB1 was 3 μg/kg, while for
T-2 toxin, it was 10 μg/kg. The diet fed to the control group did not contain detectable
amounts of T-2 and FB1.
Blood and liver tissue sampling
Fresh venous blood was sampled into heparinized (20 IU/mL whole blood) tubes and was
centrifuged for 10 min at 1,000g, at the end of the 4 weeks. Plasma was removed and stored
at −70 °C for sphinganine and sphingosine analysis (Determination of the plasma sphinga-
nine (Sa) to sphingosine (So) ratio section).
After exsanguination, whole livers were immediately dissected and weighed. Tissue
samples of ca. 5 g were cut with scissors in a medium according to Brand et al. (5).
Liver samples were rinsed and resuspended in 10 volumes of ice-cold medium, contain-
ing 250 mM sucrose, 5 mM Tris/HCl, and 2 mM EGTA (pH 7.4 at 4 °C), then
homogenized using six passes of a motorized Teﬂon/glass Potter-Elvehjem homogenizer.
All chemicals were purchased from Sigma-Aldrich (Schnelldorf, Germany). The homoge-
nate was centrifuged at 1,000g for 3 min, and the supernatant was centrifuged at 12,000g
for further 10 min at 4 °C. The pellet was then suspended, respun at 12,000g for 10 min
(MLW K24 Janetzky, Engelsdorf, Germany), and resuspended in isolation medium and
kept at −70 °C.
Lipid analysis
Whole tissue samples as well as isolated mitochondria were homogenized (T25 Digital
Ultra Turrax, IKA, Staufen, Germany) in a 20-fold volume of chloroform:methanol
(2:1, vol:vol) and the total lipid content was extracted (16). Solvents were ultrapure grade
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(Sigma-Aldrich, Schnelldorf, Germany) and 0.01% w:v butylated hydroxytoluene was
added to prevent FA oxidation. In the frame of lipid fractionation, extracted total lipids
were transferred to glass chromatographic columns, containing 300 mg silica gel (230–400
mesh) for 10 mg of lipids (24). Neutral lipids were eluted with 10 mL chloroform for the
above fat amount, then 15 mL acetone:methanol (9:1, vol:vol) was added, while 10 mL
pure methanol eluted the total PLs. This latter fraction was evaporated to dryness under a
nitrogen stream and was transmethylated with a base-catalyzed NaOCH3 method (9). FA
methyl esters were extracted into 300 μL ultrapure n-hexane for gas chromatography.
Latter was performed on a Shimadzu 2010 apparatus (AOC 20i automatic injector),
equipped with a Phenomenex Zebron ZB-WAX Capillary GC column (30 m × 0.25 mm
ID, 0.25 μm ﬁlm, Phenomenex Inc., Torrance, CA, USA) and ﬂame ionization
detector (FID, 2 × 10−11). Characteristic operating conditions were: injector temperature,
270 °C; detector temperature, 300 °C; and helium ﬂow, 28 cm/s. The oven temperature
was graded from 80 °C to 205 °C: 2.5 °C/min, 5 min at 205 °C; and from 205 °C to 250 °C:
10 °C/min, 5 min at 210 °C. The makeup gas was nitrogen. To identify the individual
FA, an authentic external FA standard (37 Component FAME Mix, Sigma-Aldrich,
Cat No: CRM47885) was used. FA results were expressed as weight % of total FA
methyl esters.
Unsaturation index (UI) was deﬁned as the number of double bonds in 100 fatty acyl
chains. From the FA results, UI was calculated as: UI= [(1 × Σ monoenoic FA)+ (2 × Σ
dienoic FA) + (3 × Σ trienoic FA) + (4 × Σ tetraenoic FA)+ (5 × Σ pentaenoic FA) + (6 × Σ
hexaenoic FA)] (7). The average fatty acyl chain length (ACL) was calculated from the
multiplication of the chain length values and the respective proportion of each FA.
Assessment of antioxidant defense capacity
Lipid peroxidation was assessed in blood plasma with the determination of malondialdehyde
(MDA) levels with 2-thiobarbituric acid method (30). The concentration of plasma reduced
glutathione (GSH) was measured with photometry (31) and the activity of plasma glutathione
peroxidase (GSHPx) according to Lawrence and Burk (22).
Determination of the plasma sphinganine (Sa) to sphingosine (So) ratio
Determination of Sa/So was carried out using acetonitrile (900 μL) addition to the plasma
(100 μL) and the mixture was centrifuged at 10,000 rpm for 5 min and ﬁltered through a
0.45 μm ﬁlter. Sphinganine and sphingosine levels were determined by LC-MS. Chro-
matographic separation was carried out using a Waters Symmetry C18 column (150 mm ×
2.1 mm, ID 5 μm; Waters, Mildford, MA, USA). Quantitative measurement was based on
linear calibration to authentic standards.
Statistical evaluation
For the comparison of group means (bodyweight and liver weight FA proﬁle), multivariate
analysis of variance was used (evaluating the interactions as well) with the Tukey post hoc
test for the inter-group differences, preceded with the analysis of normal distribution
(Kolmogorov–Smirnov test) (19).
Ethical statement
The experiment was carried out according to the regulations of the Hungarian Animal
Protection Act. The allowance number for this study was 656-1/2012.
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Results
Bodyweight and liver weight
After 4 weeks of feeding, the T-2 and the T-2+FB1 groups’ bodyweight were signiﬁcantly
lower compared to the control or even to the pure FB1 data, although the feed intake was not
different among the groups (data not shown). The liver weight at the end of the experiment in
the group fed with T-2 toxin was signiﬁcantly higher compared to the other treatment groups
and reached ca. three times higher weight than the control (Table I). However, T-2+FB1 in
combination or FB1 alone did not signiﬁcantly alter liver weight.
Hepatic total phospholipids
From Table II, showing the total hepatic PL FA composition, it is clear that all three toxin
treatments decreased the proportion of palmitoleic acid (C16:1 n7). Arachidic acid (C20:0)
proportion in the liver total PL fraction was increased by the combined toxin treatment
(T-2+FB1) compared to the control. Interestingly, the UI was the highest in the combined
toxin (T-2+FB1) exposed animals, differing signiﬁcantly only from the control, but not from
the two individual toxin treatments (T-2 and FB1 separately). A totally identical alteration
was observed in the ACL. Altogether, neither the separated nor the combined mycotoxin
treatments induced drastic FA compositional alteration in the hepatic total PLs.
Liver mitochondrial phospholipids
In the isolated mitochondria, the membrane lipids revealed to be more prone towards the
mycotoxin exposure. Table III summarizes the results concerning the alterations of the
mitochondrial membrane PL FA composition. Margaric acid (C17:0) proportion was
decreased in both separated toxin treatments compared to the combined setting. Oleic acid
(C18:1 n9) (a major membrane component of the PL fraction) proportion was signiﬁcantly
increased by FB1. Arachidonic acid (C20:4 n6) was decreased in the FB1 group compared to
the control and the binary mixture treatment. Docosapentaenoic acid (C22:5 n3) proportion
was decreased signiﬁcantly in both separate treatments compared to the combined group, but
not differing from the control.
In the calculated FA data, total monounsaturation (MUFA) was signiﬁcantly higher in
the FB1 group compared to the control. A completely opposite result was found for the total
polyunsaturation, while the total n3 FA proportion was increased (on the expense of the total
n6 FAs).
Table I. Liver and bodyweight of the four experimental groups (mean ± SD)
Group Liver weight (g; day 60) Bodyweight (g; day 60)
Mean ± SD Mean ± SD
T-2 219.2 ± 3.37b 2280 ± 82.6A
FB1 75.8 ± 4.35
ab 2695 ± 84.1B
T-2+FB1 72.8 ± 4.35
a 2221 ± 81.7A
Control 91 ± 8.39ab 2653 ± 69B
a,b,A,BDifference between treatments at day 60
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Table II. The total hepatic phospholipid fatty acid composition of the control and the toxin-treated groups (all data are
mean ± SD of six animals)
Group T-2 FB1 T-2+FB1 Control
Liver PL Mean ± SD Mean ± SD Mean ± SD Mean ± SD
C14:0 0.06 ± 0.01 0.08 ± 0.02 0.07 ± 0.01 0.12 ± 0.09
C15:0 0.19 ± 0.03 0.17 ± 0.04 0.20 ± 0.02 0.17 ± 0.04
C16:0 19.1 ± 0.97 19.2 ± 1.33 17.5 ± 1.73 20.3 ± 2.81
C16:1 n7 0.39 ± 0.13a 0.45 ± 0.05a 0.31 ± 0.14a 0.66 ± 0.22b
C17:0 0.85 ± 0.12b 0.72 ± 0.14ab 0.91 ± 0.07b 0.63 ± 0.11a
C18:0 24.4 ± 0.96 23.1 ± 1.08 24.1 ± 1.88 22.5 ± 1.64
C18:1 n9c 13.5 ± 2.20 15.2 ± 0.91 13.8 ± 1.13 15.3 ± 1.43
C18:2 n6c 29.2 ± 2.47 29.1 ± 0.74 29.1 ± 0.07 28.4 ± 2.38
C18:3 n6c 0.09 ± 0.09 0.04 ± 0.01 0.05 ± 0.01 0.09 ± 0.08
C18:3 n3 0.50 ± 0.06 0.55 ± 0.09 0.51 ± 0.03 0.49 ± 0.14
C20:0 0.04 ± 0.00a 0.04 ± 0.00a 0.05 ± 0.01b 0.04 ± 0.01a
C20:1 n9 0.27 ± 0.05 0.32 ± 0.16 0.35 ± 0.15 0.31 ± 0.12
C20:2 n6 0.68 ± 0.14 0.89 ± 0.17 0.90 ± 0.29 0.75 ± 0.26
C22:0 0.42 ± 0.35 0.27 ± 0.06 0.34 ± 0.16 0.38 ± 0.22
C20:3 n6 0.93 ± 0.27 0.88 ± 0.11 1.07 ± 0.21 0.95 ± 0.30
C20:3 n3 0.03 ± 0.01 0.03 ± 0.01 0.04 ± 0.03 0.03 ± 0.01
C20:4 n6 7.96 ± 0.48 7.40 ± 0.98 9.06 ± 1.66 7.41 ± 0.55
C22:5 n3 0.25 ± 0.04 0.23 ± 0.06 0.31 ± 0.07 0.24 ± 0.05
C22:6 n3 0.17 ± 0.04 0.15 ± 0.05 0.19 ± 0.06 0.17 ± 0.05
Saturated 45.0 ± 1.43 43.6 ± 1.05 43.2 ± 1.11 44.1 ± 1.48
Monoenoic 14.1 ± 2.31 16.0 ± 1.02 14.5 ± 1.42 16.3 ± 1.66
PUFA 39.8 ± 2.67 39.3 ± 1.05 41.2 ± 1.72 38. 6 ± 2.73
n3 0.95 ± 0.13 0.96 ± 0.17 1.05 ± 0.11 0.92 ± 0.17
n6 38.9 ± 2.60 38.3 ± 0.93 40.2 ± 1.63 37.6 ± 2.70
n6/n3 41.2 ± 4.26 40.8 ± 6.17 38.7 ± 3.41 42.0 ± 6.58
UI 112.7 ± 3.90ab 112.22 ± 3.40ab 118.39 ± 6.09b 111.1 ± 4.88a
ACL 17.66 ± 0.04ab 17.64 ± 0.05ab 17.70 ± 0.10b 17.62 ± 0.06a
UI= unsaturation index; ACL= average fatty acyl chain length
a,bSigniﬁcant (P< 0.05) difference between groups
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Antioxidant defense capacity
In the blood plasma, the concentration of reduced GSH was the highest in the control,
signiﬁcantly differing from all toxin-treated groups. Identical ﬁnding was detected by
GSHPx, but no alteration was detected in the plasma MDA concentration (Fig. 1).
Table III. The hepatic mitochondrial phospholipid fatty acid composition of the control and the toxin-treated groups
(all data are mean ± SD of six animals)
Group T-2 FB1 T-2+FB1 Control
Liver mitochondrial PL Mean ± SD Mean ± SD Mean ± SD Mean ± SD
C14:0 0.21 ± 0.19 0.28 ± 0.12 0.15 ± 0.10 0.22 ± 0.16
C15:0 0.20 ± 0.10 0.21 ± 0.08 0.27 ± 0.04 0.24 ± 0.06
C16:0 20.6 ± 2.03 21.0 ± 3.73 18.2 ± 1.24 18.4 ± 1.78
C16:1 n7 1.27 ± 0.46 1.20 ± 0.17 0.75 ± 0.23 1.13 ± 0.43
C17:0 0.61 ± 0.18a 0.60 ± 0.16a 0.92 ± 0.15b 0.79 ± 0.17ab
C18:0 17.3 ± 1.05 16.5 ± 1.00 18.3 ± 4.39 16.7 ± 4.60
C18:1 n9c 23.4 ± 4.68ab 26.8 ± 1.56b 20.3 ± 3.63ab 19.1 ± 4.99a
C18:2 n6c 25.6 ± 5.63 22.0 ± 6.05 28.7 ± 4.24 30.3 ± 3.78
C18:3 n6 0.19 ± 0.06 0.38 ± 0.17 0.09 ± 0.05 0.19 ± 0.24
C18:3 n3 1.61 ± 0.80 2.04 ± 0.60 1.23 ± 0.40 1.92 ± 1.21
C20:0 0.08 ± 0.02 0.09 ± 0.02 0.08 ± 0.01 0.08 ± 0.03
C20:1 0.70 ± 0.37 0.86 ± 0.59 0.51 ± 0.18 0.46 ± 0.12
C20:3 n6 0.90 ± 0.44 0.80 ± 0.37 1.39 ± 0.31 1.28 ± 0.45
C20:3 n3 0.23 ± 0.04ab 0.27 ± 0.20b 0.07 ± 0.03ab 0.23 ± 0.11ab
C20:4 n6 4.83 ± 1.05ab 4.04 ± 0.34a 6.39 ± 1.58b 6.43 ± 1.32b
C22:5 n3 0.19 ± 0.04a 0.18 ± 0.02a 0.28 ± 0.05b 0.25 ± 0.06ab
C22:6 n3 0.83 ± 0.34 1.41 ±1.15 0.63 ± 0.53 0.55 ± 0.24
Saturated 39.0 ± 1.57 38.6 ± 4.12 37.9 ± 4.50 36.4 ± 4.23
Monoenoic 23.5 ± 4.34ab 28.7 ± 1.37b 21.7 ± 3.66ab 20.8 ± 4.97a
PUFA 34.4 ± 5.69ab 31.1 ± 5.43a 38.7 ± 4.87ab 41.2 ± 4.55b
n3 2.85 ± 1.03ab 3.90 ± 0.82b 2.20 ± 0.44a 2.95 ± 1.55a
n6 31.6 ± 6.55ab 27.2 ± 6.04a 36.5 ± 5.15ab 38.2 ± 4.87b
n6/n3 12.8 ± 6.71 7.37 ± 2.53 17.6 ± 6.09 16.9 ± 11.5
UI 102.9 ± 20.0 108.7 ± 5.44 118.0 ± 9.68 122.5 ± 9.39
ACL 17.5 ± 0.14 17.5 ± 0.17 17.5 ± 0.13 17.5 ± 0.10
UI= unsaturation index; ACL= average fatty acyl chain length
a,bSigniﬁcant (P< 0.05) difference between groups
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Plasma sphinganine (Sa) to sphingosine (So) ratio
After 4 weeks of mycotoxin exposure, plasma sphinganine/sphingosine ratio was increased
by FB1 alone, but to a lesser extent, even in combination with T-2 toxin, while T-2 toxin
alone did not inﬂuence the plasma Sa/So ratio (Fig. 2).
Discussion
Bodyweight and liver weight
The toxin exposure lasted for 28 days until the animals reached the approximate Hungarian
conventional slaughter weight. T-2 alone or in combination (with FB1) appeared as a growth
depressing factor. Meanwhile, FB1 was administered in a relatively high dose (10 mg/kg
feed), as a single toxin, it had no detectable effect either on bodyweight or on liver weight
compared to the control.
In contrast, T-2 toxin led to a marked growth depression, independently of the adminis-
tration type (single toxin or co-occurring with FB1). In a recent study (34), the <0.02 mg/kg
bodyweight/day T-2 concentration valuewas deﬁned as the no observed adverse effect level for
rabbit bucks. This present treatmentwas exceeding this value (ca. 0.96mg/kg bodyweight/day),
leading towell-established compromised growth. The threefold increased liverweight (as in this
study) is a well-known consequence even in acute T-2 toxicosis in rabbits, accompanied by
Fig. 1. The extent of antioxidant
capacity (GSH, GSHPx) and the
concentration of the ultimate lipid
peroxidation product,
malondialdehyde, in the blood
plasma of the rabbits (mean ± SD)
Fig. 2. The plasma sphinganine to
sphingosine ratio after 4 weeks of
feeding FB1, T-2 toxin, and
T-2+FB1 compared to the control
(mean ± SD)
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centrilobular dystrophy (34). The most remarkable pathological ﬁndings included enlarged,
friable, pale, and yellowish liver with spot-like necrotic areas (unpublished data). The results
clearly refer to the hypothesis that T-2 toxin, as a type A trichothecene with its characteristic
hydroxyl and ester groups [thus being amphipathic (27)], exerts a direct hepatotoxic effect,
unequivocally supporting the hypothesis that it – due to its molecular characteristics –
effectively crosses the hepatocellular membrane (i.e., the amphipathic PLs) (10).
Fatty Acid Composition
Hepatic total phospholipids
In spite of the dramatically enlarged liver, T-2 toxin alone was less affecting the hepatic total
PL fatty acyl chain composition. There was no single FA of which T-2 toxin clearly altered the
proportion compared to any of the other (combined or single) toxin treatments. Altogether, one
monounsaturated (C16:1 n7, palmitoleic acid) and one odd chain (C17:0, margaric acid) FA
showed the altered proportion in the liver total PLs of the T-2 toxin group compared to the
control. It was interesting that even on the calculated FA parameters, T-2 toxin only had a slight
effect, not differing signiﬁcantly from the control, even not in the UI value.
The only hint that FB1 alters hepatic (microsomal) membrane lipid palmitoleic acid
proportion has been published by Gelderblom et al. (17). These authors described a disturbed
microsomal lipid metabolism with increased delta-9 desaturase activity (not proven in the
hepatic total PLs in our study), but it has to be added that in the cited study, 100 mg/kg feed
FB1 was fed to rats (carcinogenic level). Interestingly, the inhibition of ceramide synthase by
FB1was not reﬂected in themicrosomalmembrane lipids (17), even at this high-dose treatment.
As the ﬁrst-level interpretation, for FB1, identical results were found to that of T-2 toxin
in the liver total PLs. However, compared to the rat microsomal membranes, FB1 alone was
not a very potent modulator/disruptor of hepatic total PL FA composition, neither inducing
liver weight alteration.
In contrast, the combined application (T-2+FB1) of the two mycotoxins compared to the
control or even the individual toxin exposures, was “effective;” in that, this treatment reduced
the C16:1 n7 proportion (but did not perturb delta-9 desaturation signiﬁcantly!) and
slight, but signiﬁcant increase was found for arachidic acid, the UI and the ACL. In the
multivariate statistical model, there was no interaction for ACL between the treatments
(i.e., T-2 and FB1), but for C16:1 n7, C20:0, and UI, the interaction (i.e., T-2 × FB1) of the
two toxins was signiﬁcant at the level of P< 0.001. We thus suppose a synergism in these
cases, the two fusariotoxins augmenting their common effects upon the latter FAs and
unsaturation.
Comparing our results with the literature data, it must be emphasized that total hepatic
PLs have not yet been analyzed as the targets of combined T-2+FB1 toxins. It thus seems that
at the moderately high levels, neither T-2 toxin nor FB1 are hepatocellular membrane
disruptors in the leporine model, when the exposure is relatively short (4 weeks), but T-2
toxin provides a rather effective translocation across the hepatocellular membrane with major
parenchymal consequences.
Liver mitochondrial phospholipids
In isolated mitochondria, the PLs were more strongly modiﬁed by the mycotoxin exposure.
Margaric acid (C17:0) proportion was decreased by both individual toxin treatments (T-2 and
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FB1) compared to the combined setting, while the combined treatment increased its
proportion (but was not different from the control). Their statistical interaction in the
multivariate model was signiﬁcant (P< 0.001), suggesting a synergistic effect. In rabbit
tissue membranes, margaric acid abundance is clearly dependent on two factors: odd
chain FAs are exclusively synthesized by the gut microﬂora and odd chain saturated
FAs are peripherally (position sn-1) located in PC and are primary targets of beta
oxidation (being quasi-equivalent with paired chain saturated FAs in this respect), when
hydrolyzed by the most abundant PLase A2 (24). The enzymatic cleavage of an odd chain
saturated FA at position sn-1 may be a part of the Lands mechanism (8, 21), a means to
regulate membrane ﬂuidity via the modiﬁcation of the glycerolipid FA side chain
combinations.
Oleic acid (C18:1 n9) proportion was signiﬁcantly increased only in the FB1 group, and
in the combined treatment, the difference was not signiﬁcant among individual treatments
and control. In our earlier study (33), in the erythrocyte membrane, oleic acid provided the
highest proportion in the combined treatment. This partly agrees with the results of
Gelderblom et al. (17), who reported that FB1 at 100 mg/kg feed induced delta-9 desaturase
activation and increased membrane monounsaturation. It is important to add that we only fed
4 weeks of this concentration, but it is a necessary addition that rabbits perform coecotrophy
(33), while rats perform coprophagy (17); this means that the exact toxin (or mycotoxin
metabolite) concentration at the site of action (liver) is with the highest probability higher
than that in the feed. The reason why FB1 seems to be a more potent modulator of delta-9
desaturation may be due to the lower stability of T-2 toxin, which is very quickly
enzymatically hydrolyzed to HT-2 (10). Meanwhile, FB1 is a more stable molecule and
there are further factors to be considered in rabbits. In monogastric animals (piglets), the
accumulative absorption of FB1 is only ca. 4% (15). However, as a result of coecotrophy in
rabbit, the accumulative absorption may increase, while the hidden proportion, occurring in a
matrix associated form may be liberated as well by the digestive enzymes (during the
multiplied uptake via coecotrophy), leading ultimately to a higher toxin exposure than
determined analytically from the food (34).
The biological background to decrease polyunsaturation in parallel to increase mono-
unsaturation is a means to maintain membrane ﬂuidity by decreasing the sensitivity toward
lipid peroxidation (29). Although it was not directly measured from the liver, in the blood
plasma, the concentration of reduced GSH was the highest in the control, signiﬁcantly
differing from all other toxin treatments, referring to an effective scavenger role against the
emerging reactive oxygen substances (Fig. 1). The same alteration was found for GSHPx, but
no alteration was detected in the plasma MDA concentration. MDA is formed in the terminal
phase of lipid peroxidation from FAs having at least three double bonds, and is strongly
cytotoxic (24). In this study, the extent of lipid peroxidation as assessed from the blood
plasma was maintained at a relatively low level.
It thus seems that the cross-membrane transport has a more widespread effect, even
detectable in the systemic circulation (4), as published for T-2 (broiler chickens) and for FB1
in pigs (20). The role of GSHPx is to “up-oxidate” the reduced GSH moiety. Indeed, our
results supported this fact, namely, GSHPx was likewise in a more saturated enzymatic phase
compared to the control.
Mitochondrial membrane arachidonic acid (C20:4 n6) proportion decreased only in the
FB1 group compared to the control and the binary mixture treatment. In the biological
membranes, primarily in PLs, arachidonic acid is the root component of the eicosanoids
330 Szabo´ et al.
Physiology International (Acta Physiologica Hungarica) 103, 2016
liberated via the activity of phospholipase A2. Although different cell organelles and lipid
fractions react with FB1-induced stimuli divergently, Burger et al. (6) reported supportive
results in which FB1 was liberated from the PC fraction, augmenting prostaglandin E2 series
synthesis and inducing sustaining cell proliferation (2). The further fact to take into account is
that impaired arachidonic acid metabolism, in particular its proportional decrease in the PC
fraction has been implied as a growth stimulus for hepatocellular nodules (1).
Docosapentaenoic acid (C22:5 n3) proportion was decreased signiﬁcantly in both
separate treatments compared to the combined group, but not differing from the control.
According to Abel et al.’s study (1), the proportional decrease of C20–C22 FAs is a factor to
control/improve antioxidant properties. This is underpinned by the fact that although the
pentaenoic FA proportion and the monounsaturation were increased, there was a ca. 4-fold
difference in the peroxidation sensitivity between oleic and docosapentaenoic acids (18).
In the calculated FA data, total monounsaturation (MUFA) was signiﬁcantly higher in the
FB1 group compared to the control. A completely opposite result was found for the total
polyunsaturation, while the total n3 FA proportion increased.
Summarizing the above ﬁndings in the mitochondrial FA composition, Burger et al. (6)
reported that the modiﬁed FA proﬁle may be coupled with an altered growth pattern of FB1-
intoxicated hepatocytes, including as well the perturbation of the ceramide synthesis. Indeed,
we did not measure hepatocellular, but only plasma sphinganine/sphingosine ratio, it was
found that FB1 alone, but to a lesser extent, even in combination with T-2 was able to
markedly increase this ratio, while T-2 did not inﬂuence the plasma Sa/So ratio (Fig. 2).
In conclusion, it was found that at the predeﬁned mycotoxin concentration values in
young rabbits were more prone toward T-2 toxin administration, which slightly alters hepatic
plasma and mitochondrial membrane composition. When T-2 toxin was fed in combination
with FB1, synergistic effects were proven for saturated (C16:0, C17:0, C20:0) and mono-
unsaturated FAs. All toxin treatments induced lipid peroxidation and activated the antioxi-
dant defense (GSHPx). Fumonisin was, moreover, proven to perturb membrane ceramide
homeostasis, even at a moderate concentration and at a relatively short exposure time.
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